Skip to main content
OpenTrials
Completed

NCT Number: NCT00775099

Combustion Derived Air Pollution and Vascular Function

Air pollution is a major cause of cardiovascular morbidity and mortality. The components of air pollution responsible and the mechanisms through which they might mediate these harmful effects remain only partially understood. The link between cardiovascular disease and air pollution is strongest for fine particulate matter. Fine particulate matter (PM) is produced from the combustion of fossil fuels with the most significant threat thought to be posed by small particles less than 10µm (PM 10) which can be inhaled into the lungs. We propose to identify the precise component of diesel exhaust that mediates the adverse cardiovascular effects using a carbon particle generator, and a particle concentrator. The aim of this study proposal is to assess the vascular effects of different types and components of air pollution in healthy subjects. We intend to test the hypotheses that:

1. Combustion derived nanoparticulate causes an acute impairment of endothelial vasomotor and fibrinolytic function in healthy volunteers. 2. Exposure to combustion derived air pollution is associated with increased thrombus formation.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Edinburgh

Edinburgh, EH16 4SB, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy volunteers

Exclusion criteria

  • Current smokers
  • Significant occupational exposure to air pollution
  • History of lung disease
  • Women of child-bearing potential
  • Malignant arrhythmias
  • Renal or hepatic failure
  • Significant co-morbidity
  • Systolic blood pressure >190 or <100 mmHg
  • Previous history of blood dyscrasia
  • Unable to tolerate the supine position
  • Lack of informed consent
  • Blood donation within last 3 months

Treatment and study plan

Forearm Vascular Study

Procedure

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 mg/min).

Other names: BK, SNP, ACh

Badimon Chamber

Procedure

Ex-vivo assessment of thrombus formation using Badimon Chamber

Primary outcomes

  1. Forearm blood flow measured by forearm venous occlusion plethysmography in response to infused vasodilators

    Time frame: 6-8 hours after exposure

Secondary outcomes

  1. Ex-vivo thrombus formation assessed using the Badimon chamber

    Time frame: 6 hours after exposure

  2. Arterial stiffness measured by radial artery tonometry

    Time frame: Before and after exposure

  3. Heart rate and heart rate variability measured with 3 lead Holter electrographic monitors

    Time frame: During and for 24 hours after exposure

  4. Blood pressure

    Time frame: During and after exposure and during forearm study

  5. Plasma t-PA and PAI concentrations following infusion of bradykinin

    Time frame: During forearm study

  6. Plasma inflammatory markers IL-6, TNF-alpha, IL-1 and hsCRP

    Time frame: Before and after exposure

  7. Platelet monocyte binding as measured by flow cytometry

    Time frame: After the exposure

Sponsors and collaborators

Lead sponsor

University of Edinburgh

Other

Collaborators

  • National Institute for Public Health and the Environment (RIVM)

Registry information

Official study title

The Effects of Combustion-Derived Air Pollution on Vascular Vasomotor and Fibrinolytic Function in Healthy Volunteers (Diesel Exposure)

Important dates

Study start
2005
Primary completion
2006
Study completion
2006
First posted
Oct 17, 2008
Registry last updated
Oct 17, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.